While it’s true that President Trump shouldn’t oversell the chances that antimalarial drugs will provide major relief to symptoms of the coronavirus, his instincts in favor of letting people try them are actually laudable.
The media should push harder with follow-up questions to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, about whether any downside risks to those drugs really do merit his “go slow” predilections. Are the risks worse than the coronavirus?
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.